Notice of Closed Meeting, 9362 [2022-03554]
Download as PDF
<![CDATA[
9362
Federal Register / Vol. 87, No. 34 / Friday, February 18, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES1
This RFI is for planning purposes
only and should not be construed as a
policy, solicitation for applications, or
as an obligation on the part of the
Government to provide support for any
ideas identified in response to it. AHRQ
will use the information submitted in
response to this RFI at its discretion and
will not provide comments to any
responder’s submission. However,
responses to the RFI may be reflected in
future solicitation(s) or policies. The
information provided will be analyzed
and may appear in reports. Respondents
will not be identified in any published
reports. Respondents are advised that
the Government is under no obligation
to acknowledge receipt of the
information received or provide
feedback to respondents with respect to
any information submitted. No
proprietary, classified, confidential, or
sensitive information should be
included in your response. The contents
of all submissions will be made
available to the public upon request.
Materials submitted must be publicly
available or able to be made public.
Collaborative: Using Data to Promote the
Health and Wellness of People with
Disabilities.
Date: May 3, 2022.
Time: 11:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
National Center for Chronic Disease
Prevention and Health Promotion, CDC,
4770 Buford Highway, Mailstop S107–
B, Atlanta, Georgia 30341, Telephone:
(770) 488–6511, Email: JRaman@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: February 15, 2022.
Marquita Cullom,
Associate Director.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–03551 Filed 2–17–22; 8:45 am]
[FR Doc. 2022–03554 Filed 2–17–22; 8:45 am]
BILLING CODE 4160–90–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–PS–22–
001, Implementing Pre-Exposure
Prophylaxis for HIV Prevention in
Syringe Service Programs; RFA–PS–
22–002, Implementation Research on
Telehealth Strategies To Support
Retention in Care and Treatment
Among Antiretroviral Therapy (ART)
Patients and Pre-Exposure Prophylaxis
(PrEP) Clients and RFA–PS–22–004,
Understanding HIV/STD Risk and
Enhancing PrEP Implementation
Messaging in a Diverse CommunityBased Sample of Gay, Bisexual, and
Other Men Who Have Sex With Men in
a Transformational Era; Amended
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP22–004, Disability and Health Data
VerDate Sep<11>2014
18:54 Feb 17, 2022
Jkt 256001
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP) RFA–PS–
22–001, Implementing Pre-exposure
Prophylaxis for HIV Prevention in
Syringe Service Programs; RFA–PS–22–
002, Implementation Research on
PO 00000
Frm 00056
Fmt 4703
Sfmt 9990
Telehealth Strategies to support
Retention in Care and Treatment among
Antiretroviral Therapy (ART) Patients
and Pre-exposure Prophylaxis (PrEP)
Clients; and RFA–PS–22–004,
Understanding HIV/STD Risk and
Enhancing PrEP Implementation
Messaging in a Diverse CommunityBased Sample of Gay, Bisexual, and
Other Men Who Have Sex with Men in
a Transformational Era.
Date: March 30, 2022.
Time: 10:00 a.m.–5:00 p.m. (EDT).
Place: Teleconference.
The meeting was published in the
Federal Register on February 4, 2022,
Volume 87, Number 24, page 6562–
6563.
The meeting is being amended to
remove RFA–PS–22–002,
Implementation Research on Telehealth
Strategies to Support Retention in Care
and Treatment among Antiretroviral
Therapy (ART) Patients and Preexposure Prophylaxis (PrEP) Clients and
should read as follows:
RFA–PS–22–001, Implementing Preexposure Prophylaxis for HIV
Prevention in Syringe Service Programs
and RFA–PS–22–004, Understanding
HIV/STD Risk and Enhancing PrEP
Implementation Messaging in a Diverse
Community-Based Sample of Gay,
Bisexual, and Other Men Who Have Sex
with Men in a Transformational Era.
The meeting is closed to the public.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, CDC, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329, Telephone: (404) 718–
8833, Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–03555 Filed 2–17–22; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\18FEN1.SGM
18FEN1
]]>Agencies
[Federal Register Volume 87, Number 34 (Friday, February 18, 2022)]
[Notices]
[Page 9362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03554]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--SIP22-004, Disability and Health
Data Collaborative: Using Data to Promote the Health and Wellness of
People with Disabilities.
Date: May 3, 2022.
Time: 11:00 a.m.-6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Jaya Raman, Ph.D., Scientific
Review Officer, National Center for Chronic Disease Prevention and
Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-B, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03554 Filed 2-17-22; 8:45 am]
BILLING CODE 4163-18-P
